Douglas Loe
Stock Analyst at Leede Financial
(4.63)
# 868
Out of 4,504 analysts
152
Total ratings
47%
Success rate
22.4%
Average return
Main Sectors:
Stocks Rated by Douglas Loe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $22.68 | $13.53 | +67.61% | 3 | Mar 11, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Reiterated: Buy | $3.00 | $0.33 | +809.09% | 3 | Mar 8, 2026 | |
| TSXV: NSCI Nanalysis Scientific Corp. | Maintained: Buy | $0.50 | $0.125 | +300.00% | 1 | Nov 27, 2025 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $8.5 → $4 | $0.8873 | +350.81% | 18 | Nov 25, 2025 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Maintained: Buy | $6.38 → $15.59 | $1.44 | +982.70% | 5 | Aug 8, 2025 | |
| PMN ProMIS Neurosciences | Maintained: Buy | n/a | $14.25 | - | 2 | Jul 22, 2025 | |
| TSX: DR Medical Facilities Corporation | Maintained: Buy | $4.50 → $15.50 | $18.15 | n/a | 7 | Aug 7, 2024 | |
| TSX: SVA Sernova Biotherapeutics Inc | Maintained: Buy | $3.30 → $4.68 | $0.125 | n/a | 9 | Jun 30, 2023 | |
| TSX: EXE Extendicare Inc. | Maintained: Hold | $8.25 → $7.00 | $37.00 | n/a | 13 | May 8, 2023 | |
| IMVIF IMV Inc. | Reiterated: Buy | $7.41 → $42 | $0.000001 | n/a | 18 | Apr 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $0.25 | $0.015 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.99 → $0.11 | $2.45 | n/a | 12 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.53 | $0.000001 | n/a | 13 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.00 | $3.50 | n/a | 12 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27.00 → $29.00 | $45.92 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $17.13 | n/a | 17 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37.50 | $10.05 | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.000001 | n/a | 2 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $1 | $4.80 | n/a | 4 | Oct 7, 2019 |
Satellos Bioscience Inc.
Mar 11, 2026
Maintained: Buy
Price Target: $22.68
Current: $13.53
Upside: +67.61%
Perimeter Medical Imaging AI, Inc.
Mar 8, 2026
Reiterated: Buy
Price Target: $3.00
Current: $0.33
Upside: +809.09%
Nanalysis Scientific Corp.
Nov 27, 2025
Maintained: Buy
Price Target: $0.50
Current: $0.125
Upside: +300.00%
Oncolytics Biotech
Nov 25, 2025
Maintained: Buy
Price Target: $8.5 → $4
Current: $0.8873
Upside: +350.81%
Cardiol Therapeutics Inc.
Aug 8, 2025
Maintained: Buy
Price Target: $6.38 → $15.59
Current: $1.44
Upside: +982.70%
ProMIS Neurosciences
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $14.25
Upside: -
Medical Facilities Corporation
Aug 7, 2024
Maintained: Buy
Price Target: $4.50 → $15.50
Current: $18.15
Upside: n/a
Sernova Biotherapeutics Inc
Jun 30, 2023
Maintained: Buy
Price Target: $3.30 → $4.68
Current: $0.125
Upside: n/a
Extendicare Inc.
May 8, 2023
Maintained: Hold
Price Target: $8.25 → $7.00
Current: $37.00
Upside: n/a
IMV Inc.
Apr 12, 2022
Reiterated: Buy
Price Target: $7.41 → $42
Current: $0.000001
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $2.75 → $0.25
Current: $0.015
Upside: n/a
Aug 31, 2020
Downgraded: Sell
Price Target: $0.99 → $0.11
Current: $2.45
Upside: n/a
Aug 27, 2020
Maintained: Buy
Price Target: $3.53
Current: $0.000001
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $7.00
Current: $3.50
Upside: n/a
Aug 14, 2020
Maintained: Hold
Price Target: $27.00 → $29.00
Current: $45.92
Upside: n/a
Aug 13, 2020
Maintained: Buy
Price Target: $3.00
Current: $17.13
Upside: n/a
Aug 7, 2020
Maintained: Buy
Price Target: $37.50
Current: $10.05
Upside: n/a
Jun 16, 2020
Maintained: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 7, 2019
Downgraded: Hold
Price Target: $34 → $1
Current: $4.80
Upside: n/a